Breast cancer survival and stage at diagnosis in Australia, Canada, Denmark, Norway, Sweden and the UK, 2000-2007: A population-based study

British Journal of Cancer

Volumn 108, Issue 5, 2013, Pages 1195-1208

  Walters, S ^a   Maringe, C ^a   Butler, J ^b   Rachet, B ^a   Barrett Lee, P ^c   Bergh, J ^d   Boyages, J ^e   Christiansen, P ^f   Lee, M ^g   Warnberg F ^h   Allemani, C ^a   Engholm, G ⁱ   Fornander, T ^j   Gjerstorff, M L ^k   Johannesen, T B ^l   Lawrence, G ^m   McGahan, C E ⁿ   Middleton, R ^o   Steward, J ^p   Tracey, E ^e   Turner, D ^q   Richards, M A ^r   Coleman, M P ^a   more..

^a LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

^b ROYAL MARSDEN HOSPITAL   (United Kingdom)

^c Velindre NHS Trust   (United Kingdom)

^d KAROLINSKA INSTITUTE   (Sweden)

^e CANCER INSTITUTE NSW   (Australia)

^f AARHUS UNIVERSITY HOSPITAL   (Denmark)

^g UNIVERSITY HOSPITALS COVENTRY AND WARWICKSHIRE NHS TRUST   (United Kingdom)

^h UPPSALA UNIVERSITY HOSPITAL   (Sweden)

ⁱ DANISH CANCER SOCIETY RESEARCH CENTER   (Denmark)

^j STOCKHOLM SÖDER HOSPITAL   (Sweden)

^k Danish Cancer Registry   (Denmark)

^l CANCER REGISTRY OF NORWAY   (Norway)

^m W Midlands Cancer Intelligence Unit   (United Kingdom)

ⁿ BRITISH COLUMBIA CANCER AGENCY   (Canada)

^o Northern Ireland Cancer Registry   (United Kingdom)

^p Welsh Cancer Intelligence and Surveillance Unit   (United Kingdom)

^q CANCERCARE MANITOBA   (Canada)

^r Portland House   (United Kingdom)

more..

Author keywords

breast cancer; population based; stage; survival

Indexed keywords

ADULT; AGED; ARTICLE; AUSTRALIA; BREAST CANCER; CANADA; CANCER MORTALITY; CANCER STAGING; CANCER SURVIVAL; DENMARK; FEMALE; HUMAN; MAJOR CLINICAL STUDY; NORWAY; OVERALL SURVIVAL; PRIORITY JOURNAL; SWEDEN; UNITED KINGDOM;

AGE FACTORS; AGED; AUSTRALIA; BREAST NEOPLASMS; CANADA; DENMARK; FEMALE; GREAT BRITAIN; HUMANS; MIDDLE AGED; NEOPLASM STAGING; NORWAY; POPULATION SURVEILLANCE; RISK FACTORS; SURVIVAL ANALYSIS; SWEDEN;

EID: 84875455272     PISSN: 00070920     EISSN: 15321827     Source Type: Journal    
DOI: 10.1038/bjc.2013.6     Document Type: Article

References (41)

1. Allemani C, Sant M, Weir HK, Richardson LC, Baili P, Storm H, Siesling S, Torrella-Ramos A, Voogd AC, Aareleid T, Ardanaz E, Berrino F, Bielska-Lasota M, Bolick S, Cirilli C, Colonna M, Contiero P, Cress R, Crocetti E, Fulton JP, Grosclaude P, Hakulinen T, Izarzugaza MI, Malmstrom P, Peignaux K, Primic-Zakelj M, Rachtan J, Diba CS, Sanchez MJ, SchymuraMJ, Shen T, Traina A, Tryggvadóttir L, Tumino R, Velten M, Vercelli M, Wolf HJ, Woronoff AS, Wu X, Coleman MP (2013) Breast cancer survivalin the US and Europe: a CONCORD high-resolution study. Int J Cancer132 (5) : 1170-1181.
2. Allemani C, Storm H, Voogd AC, Holli K, Izarzugaza I, Torrella-Ramos A, Bielska-Lasota M, Aareleid T, Ardanaz E, Colonna M, Crocetti E, Danzon A, Federico M, Garau I, Grosclaude P, Hédelin G, Martinez-Garcia C, Peignaux K, Plesko I, Primic-Zakelj M, Rachtan J, Tagliabue G, Tumino R, Traina A, Tryggvadóttir L, Vercelli M, Sant M (2010) Variationin 'standard care' for breast cancer across Europe: a EUROCARE-3 highresolution study. Eur J Cancer 46 (9) : 1528-1536.
3. Autier P, Boniol M, Gavin A, Vatten LJ (2011) Breast cancer mortality inneighbouring European countries with different levels of screening butsimilar access to treatment: trend analysis of WHO mortality database.BMJ 343: d4411.
4. Bastiaannet E, Liefers GJ, de Craen AJ, Kuppen PJ, van de Water W, PortieljeJE, van der Geest LG, Janssen-Heijnen ML, Dekkers OM, van de Velde CJ, Westendorp RG (2010) Breast cancer in elderly compared to youngerpatients in the Netherlands: stage at diagnosis, treatment and survival in127 805 unselected patients. Breast Cancer Res Treat 124 (3) : 801-807.
5. Berrino F, De Angelis R, Sant M, Rosso S, Bielska-Lasota M, Coebergh JW, Santaquilani M, EUROCARE Working Group (2007) Survival for eightmajor cancers and all cancers combined for European adults diagnosed in1995-99: results of the EUROCARE-4 study. Lancet Oncol 8 (9) : 773-783.
6. Birch S, Haas M, Savage E, Van GK (2007) Targeting services to reduce socialinequalities in utilisation: an analysis of breast cancer screening inNew South Wales. Aust New Zealand Health Policy 4: 12; PMID:17550622.
7. Christensen LH, Engholm G, Ceberg J, Hein S, Perfekt R, Tange UB, Andersson M, Mouridsen HT, Möller T, Storm HH (2004) Can thesurvival difference between breast cancer patients in Denmark and Sweden1989 and 1994 be explained by patho-anatomical variables A populationbasedstudy. Eur J Cancer 40 (8) : 1233-1243.
8. Coleman MP (1999) Why the variation in breast cancer survival in Europe?Breast Cancer Res 1 1 22-26.
9. Coleman MP, Forman D, Bryant H, Butler J, Rachet B, Maringe C, Nur U, Tracey E, Coory M, Hatcher J, McGahan CE, Turner D, Marrett L, Gjerstorff ML, Johannesen TB, Adolfsson J, Lambe M, Lawrence G, Meechan D, Morris EJ, Middleton R, Steward J, Richards MA. ICBPModule 1 Working Group (2011) Cancer survival in Australia, Canada, Denmark, Norway, Sweden, and the UK, 1995-2007 (the InternationalCancer Benchmarking Partnership) : an analysis of population-basedcancer registry data. Lancet 377: 127-138.
10. Coleman MP, Quaresma M, Berrino F, Lutz J-M, De Angelis R, Capocaccia R, Baili P, Rachet B, Gatta G, Hakulinen T, Micheli A, Sant M, Weir HK, Elwood JM, Tsukuma H, Koifman S, Azevedo e Silva G, Francisci S, Santaquilani M, Verdecchia A, Storm HH, Young JL, and CONCORDWorking Group (2008) Cancer survival in five continents: a worldwidepopulation-based study (CONCORD) . Lancet Oncol 9: 730-756.
11. Dowling EC, Klabunde C, Patnick J, Ballard-Barbash R (2010) Breast andcervical cancer screening programme implementation in 16 countries.J Med Screen 17 (3) : 139-146.
12. Durrleman S, Simon R (1989) Flexible regression models with cubic splines.Stat Med 8 (5) : 551-561.
13. Feinstein AR, Sosin DM, Wells CK (1985) The Will Rogers phenomenon.Stage migration and new diagnostic techniques as a source of misleadingstatistics for survival in cancer. N Engl J Med 312 (25) : 1604-1608.
14. Hackshaw A (2012) The benefits and harms of mammographic screeningfor breast cancer: building the evidence base using service screeningprogrammes. J Med Screen 19 (Suppl 1) : 1-2.
15. Jensen AR, Garne JP, Storm HH, Engholm G, Möller T, Overgaard J (2004) Does stage at diagnosis explain the difference in survival after breastcancer in Denmark and Sweden? Acta Oncol 43 8 719-726.
16. Jensen AR, Madsen AH, Overgaard J (2008) Trends in breast cancer duringthree decades in Denmark: stage at diagnosis, surgical management andsurvival. Acta Oncol 47 (4) : 537-544.
17. Jensen OM, Parkin DM, MacLennan R, Muir CS, Skeet RG (1991) Cancerregistration: principles and methods (IARC Scientific Publications No. 95) .International Agency for Research on Cancer: Lyon.
18. Jensena AR, Ewertz M, Cold S, Storm HH, Overgaard J (2003) Time trendsand regional differences in registration, stage distribution, surgicalmanagement and survival of breast cancer in Denmark. Eur J Cancer39 (12) : 1783-1793.
19. Jorgensen KJ, Zahl PH, Gotzsche PC (2010) Breast cancer mortality inorganised mammography screening in Denmark: comparative study. Br Med J 340: c1241.
20. Kalager M, Adami HO, Bretthauer M, Tamimi RM (2012) Overdiagnosis ofinvasive breast cancer due to mammography screening: results from theNorwegian screening program. Ann Intern Med 156 (7) : 491-499.
21. Koscielny S, Arriagada R, Adolfsson J, Fornander T, Bergh J (2009) Impact oftumour size on axillary involvement and distant dissemination in breastcancer. Br J Cancer 101 (6) : 902-907.
22. Lambert PC, Holmberg L, Sandin F, Bray F, Linklater KM, Purushotham A, Robinson D, Moller H (2011) Quantifying differences in breast cancersurvival between England and Norway. Cancer Epidemiol 35 (6) : 526-533.
23. Lambert PC, Royston P (2009) Further development of flexible parametricmodels for survival analysis. Stata J 9 (2) : 265-290.
24. Laurenti R, Coleman MP, Aylin P (2000) Accuracy of statements of the causeof death on death certificates and the international comparability ofmortality statistics. In Death certification and mortality statistics aninternational perspective, Coleman MP, Aylin P (eds) (Office for NationalStatistics: London.
25. Marmot MG, Altman DG, Cameron DA, Dewar JA, Thompson SG, Wilcox M (2012) The benefits and harms of breast cancer screening: an independentreview. Lancet 380 (9855) : 1778-1786.
26. Moller H, Sandin F, Bray F, Klint A, Linklater KM, Purushotham A, Robinson D, Holmberg L (2010) Breast cancer survival in England, Norway and Sweden: a population-based comparison. Int J Cancer127 (11) : 2630-2638.
27. National Institute for Health and Clinical Excellence. Breast cancer qualitystandards. http://www.nice.org.uk/guidance/qualitystandards/breastcancer/ Staging.jsp. Last accessed 2 May 2012.
28. Nur U, Shack LG, Rachet B, Carpenter JR, Coleman MP (2010) Modellingrelative survival in the presence of incomplete data: a tutorial. Int JEpidemiol 39: 118-128.
29. Parkin DM (2006) The evolution of the population-based cancer registry. NatRev Cancer 6 (8) : 603-612.
30. Pohar-Perme M, Stare J, Estève J (2012) On estimation in relative survival.Biometrics 68 (1) : 113-120.
31. Public Health Agency of Canada. Organized Breast Cancer ScreeningPrograms in Canada-Report on Program Performance in 2005 and 2006http://www.phac-aspc. gc.ca/cd-mc/publications/cancer/obcsp-podcs05/1-eng.php. Last accessed 4 December 2012.
32. Remontet L, Bossard N, Belot A, Estève J. FRANCIM (2007) An overallstrategy based on regression models to estimate relative survivaland models to estimate relative survival and model the effects ofprognostic factors in cancer survival studies. Stat Med 26 (10) :2214-2228.
33. Sankaranarayanan R, Swaminathan R, Brenner H, Chen K, Chia KS, Chen JG, Law SC, Ahn YO, Xiang YB, Yeole BB, Shin HR, Shanta V, Woo ZH, Martin N, Sumitsawan Y, Sriplung H, Barboza AO, Eser S, Nene BM, Suwanrungruang K, Jayalekshmi P, Dikshit R, Wabinga H, Esteban DB, Laudico A, Bhurgri Y, Bah E, Al-Hamdan N (2010) Cancer survival inAfrica, Asia, and Central America: a population-based study. Lancet Oncol11 (2) : 165-173.
34. Sant M, Allemani C, Capocaccia R, Hakulinen T, Aareleid T, Coebergh JW, Coleman MP, Grosclaude P, Martinez C, Bell J, Youngson J, Berrino F (2003) Stage at diagnosis is a key explanation of differences in breastcancer survival across Europe. Int J Cancer 106 (3) : 416-422.
35. Sobin LH, Gospodarowicz M, Wittekind C (2009) TNM classification ofmalignant tumours. 7th edition. Union for International Cancer Control (UICC) and Wiley-Blackwell: Oxford.
36. Voogd AC, Coebergh JW (2010) Explaining variations in survivalin breast cancer in the Eastern Region of England. Ann Oncol 21 (3) :669-670.
37. Walters S, Maringe C, Butler J, Brierley JD, Rachet B, Coleman MP (2013) Comparability of stage data in cancer registries in six countries: Lessonsfrom the International Cancer Benchmarking Partnership. Int J Cancer132 (3) : 676-685.
38. White IR, Royston P, Wood AM (2011) Multiple imputation using chainedequations: Issues and guidance for practice. Stat Med 30 (4) : 377-399.
39. Wishart GC, Greenberg DC, Chou P, Brown CH, Duffy S, Purushotham AD (2010) Treatment and survival in breast cancer in the Eastern Region ofEngland. Ann Oncol 21 (2) : 291-296.
40. Woods LM, Rachet B, O'Connell D, Lawrence G, Tracey E, Willmore A, Coleman MP (2009) Large differences in patterns of breast cancer survivalbetween Australia and England: a comparative study using cancer registrydata. Int J Cancer 124 (10) : 2391-2399.
41. Young JL, Roffers SD, Ries LAG, Fritz AG, Hurlbut AA (2001) SEERSummary Staging Manual-2000 Codes and Coding Instructions. NationalCancer Institute: Bethesda.